Karma Biotechnologies
Torrance
About Karma Biotechnologies
Karma Biotechnologies is a Los Angeles startup dedicated to solving autoimmunity, allergies, and food sensitivities with our Xavine™ precision immunotherapy platform. General immune suppression is still the standard of care for most autoimmune disease patients; there is a critical unmet need to develop antigen-specific therapies that inhibit only the disease-causing rogue immune cells. To meet this need, Karma is leveraging expertise in immunology and lipid nanoparticle engineering to develop tolerogenic immunotherapies that elicit antigen-specific immune tolerance in vivo.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $4.9M
- Funding stage: Seed
- Last round: Seed (May 2023)
- Website: karmabiotech.com
- Phone: 8183966373
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/karma-biotechnologies-56031 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.